Drugs / cH4/3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07703514 | Jul 2026 → Apr 2027 expected | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cH4/3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07703514 ↗ |
| Modality | Messenger RNA (mRNA) | “influenza A Group 1 and influenza A Group 2 mRNA chimeric hemagglutinin vaccine candidates” NCT07703514 ↗ |
| Route | Intramuscular | “given as intramuscular injections” NCT07703514 ↗ |